TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With

Gregory J Riely et al.PubMed ↗Publisher ↗

No numbers read from the abstract.